Kintara Therapeutics Stock Forecast - Accumulation Distribution
KTRADelisted Stock | USD 6.30 0.14 2.17% |
Kintara Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Kintara Therapeutics stock prices and determine the direction of Kintara Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Kintara Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
Kintara |
Previous Accumulation Distribution | Accumulation Distribution | Trend |
61790.7 | 0.29 |
Check Kintara Therapeutics Volatility | Backtest Kintara Therapeutics | Information Ratio |
Kintara Therapeutics Trading Date Momentum
On December 16 2024 Kintara Therapeutics was traded for 6.30 at the closing time. The top price for the day was 7.93 and the lowest listed price was 5.61 . There was no trading activity during the period 0.0. Lack of trading volume on December 16, 2024 did not cause price change. The trading delta at closing time against the current closing price is 2.22% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Compare Kintara Therapeutics to competition
View Kintara Therapeutics Related Equities
Risk & Return | Correlation |
Kintara Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Kintara Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Kintara Therapeutics shares will generate the highest return on investment. By undertsting and applying Kintara Therapeutics stock market strength indicators, traders can identify Kintara Therapeutics entry and exit signals to maximize returns.
Kintara Therapeutics Risk Indicators
The analysis of Kintara Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Kintara Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting kintara stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Mean Deviation | 5.18 | |||
Standard Deviation | 6.76 | |||
Variance | 45.64 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Consideration for investing in Kintara Stock
If you are still planning to invest in Kintara Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kintara Therapeutics' history and understand the potential risks before investing.
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
CEOs Directory Screen CEOs from public companies around the world | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |